Phytochemical Characterization of Hypericum perforatum Extract and Bioassay-Guided Isolation of Hypericin (Compound C1): Extraction Methodology, Structural Elucidation, and Monoaminergic Restorative Efficacy in a Reserpine-Induced Depression Model

Abstract

Background: Major Depressive Disorder (MDD) is a debilitating global public health condition characterized by monoaminergic deficits, oxidative stress, and structural neurodegeneration. Botanical preparations of Hypericum perforatum (St. John's Wort) have demonstrated multi-target antidepressant potential, yet the precise phytochemical identity of their principal bioactive constituent remains a subject of ongoing pharmacological investigation. Methods: In the present study, aerial parts of H. perforatum were subjected to a modified hydroalcoholic cold maceration protocol (70% ethanol, 72 h, 1:10 w/v). The lyophilized extract was standardized using HPLC for the primary pharmacopeial markers, hypericin and hyperforin. Bioassay-guided isolation was performed via extensive silica gel open column chromatography (60–120 mesh, gradient elution), and the resultant pure fraction was subjected to comprehensive spectroscopic characterization (MS-qTOF, FT-IR, 1H-NMR, 13C-NMR). The monoaminergic efficacy of the isolated compound (Compound C1) and the crude extract was evaluated against reserpine-induced depression in adult male Wistar rats (n = 8/group) using HPLC-ECD quantification of serotonin (5-HT), norepinephrine (NE), and dopamine (DA) in discrete brain regions. Results: The extraction yielded 18.5% (w/w) of a standardized dark-brown lyophilizate containing 0.38% hypericin and 4.6% hyperforin, surpassing pharmacopeial minima. Open-column chromatography of 20.0 g extract yielded 120 mg of a pure, dark-red crystalline compound. Spectroscopic analysis (m/z 505.09 [M+H]+; C30H16O8) unequivocally identified Compound C1 as Hypericin, a naphthodianthrone. In the reserpine-induced depression model, reserpine (2 mg/kg, i.p., three days) produced profound depletion of hippocampal 5-HT and NE, and striatal DA. Fourteen-day oral administration of Compound C1 (300 mg/kg) restored all three monoamines to levels statistically comparable to the reference standard imipramine (15 mg/kg, i.p.). Conclusion: The present investigation provides a systematic phytochemical framework establishing Hypericin as the principal bioactive constituent of H. perforatum, and furnishes definitive neurochemical evidence for its robust monoaminergic restorative activity. These findings position standardized Hypericin (Compound C1) as a highly viable multi-target therapeutic candidate for major depressive disorder.